FDA — authorised 16 February 2001
- Application: NDA020831
- Marketing authorisation holder: NOVARTIS
- Local brand name: FORADIL
- Indication: POWDER — INHALATION
- Status: approved
FDA authorised Racemic formoterol on 16 February 2001
Yes. FDA authorised it on 16 February 2001; FDA authorised it on 25 September 2001.
NOVARTIS holds the US marketing authorisation.